🔗 Permalink

Inventor profile of:

Robert Gurny

City:

Geneva

Country:

Switzerland

Published Applications:

Last publication date:

2021-02-11

Top Assignees for applications by Robert Gurny

The entities that hold a legal rights for patent applications filed by inventor Gurny Robert:

University of Geneva 6 Geneva, Switzerland
UNIVERSITE DE GENEVE 4 GENEVA 4, Switzerland
UNIVERSITE DE GENEVE 3 Geneva, Switzerland
ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC 2 Schlieren, Switzerland
SUCAMPO AG 2 Zug, Switzerland
QLT INC. 1 Vancouver, Canada
Laboratoire Medidom S.A. 1 Geneva, Switzerland
ESBATECH - A NOVARTIS COMPANY LLC 1 Zurich-Schlieren, Switzerland
SYNGENTA CROP PROTECTION, INC. 1 Greensboro, NC United States
FERRING B.V. 1 Hoofddorp, Netherlands

Recent patent applications by Gurny Robert

Robert Gurny from Geneva, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-02-11

US20210038563A1

Human necessities

NEW SPIRONOLACTONE FORMULATIONS AND THEIR USE

#2 | 2018-12-20

US20180362630A1

Chemistry; metallurgy

PROTEIN SUSTAINED-RELEASE INJECTABLE FORMULATION

#3 | 2018-09-27

US20180271984A1

Human necessities

Polylactide compositions and uses thereof

#4 | 2016-12-22

US20160367680A1

Human necessities

Polylactide compositions and uses thereof

#5 | 2016-12-15

US20160362483A1

Chemistry; metallurgy

Protein sustained-release injectable formulation

#6 | 2015-10-29

US20150306237A1

Human necessities

HYALURONIC ACID-ANTIOXIDANT CONJUGATES AND THEIR USES

#7 | 2015-07-23

US20150202295A1

Human necessities

Hybrid hydrogels

#8 | 2015-03-12

US20150073060A1

Human necessities

Polylactide compositions and uses thereof

#9 | 2015-02-12

US20150044213A1

Human necessities

Protein sustained-release injectable formulation

#10 | 2014-11-13

US20140335135A1

Human necessities

PHARMACEUTICAL COMPOSITION

#11 | 2014-06-12

US20140163217A1

Chemistry; metallurgy

PROCESS FOR THE ESTERIFICATION OF HYALURONIC ACID WITH HYDROPHOBIC ORGANIC COMPOUNDS

#12 | 2013-12-12

US20130331464A1

Human necessities

Polylactides compositions and uses thereof

#13 | 2013-10-24

US20130281638A1

Chemistry; metallurgy

TRICYCLO COMPOUND-POLYMER CONJUGATE

#14 | 2013-10-24

US20130281637A1

Human necessities

Fatty acid derivative-polymer conjugate

#15 | 2013-08-08

US20130202605A1

Human necessities

PROTEIN SUSTAINED-RELEASE INJECTABLE FORMULATION

#16 | 2013-05-23

US20130131190A1

Human necessities

Compositions comprising polymers prepared from 2-hydroxyalkyl acids

#17 | 2013-01-31

US20130028920A1

Human necessities

STABILIZED ANTIBODY PREPARATIONS AND USES THEREOF

#18 | 2013-01-17

US20130017197A1

Human necessities

STABILIZED ANTIBODY PREPARATIONS AND USES THEREOF

#19 | 2010-12-16

US20100316638A1

Human necessities

Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs

#20 | 2009-11-12

US20090281068A1

Human necessities

Polylactides compositions and uses thereof

#21 | 2009-01-01

US20090004230A1

Chemistry; metallurgy

Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate, and processes for producing the same

#22 | 2008-11-25

US10440505

Compositions and methods for delivery of photosensitive drugs

#23 | 2007-11-29

US20070275969A1

Human necessities

NANOPARTICLES FOR ORAL ADMINISTRATION OF PHARMACEUTICAL AGENTS OF LOW SOLUBILITY

#24 | 2006-07-27

US20060162249A1

Human necessities

Product for use in agriculture or horticulture

InventorID:

40192 ⎘